Search results
FY2025 EPS Estimates for Pfizer Inc. Increased by Leerink Partnrs (NYSE:PFE)
ETF DAILY NEWS· 2 days agoPfizer Inc. (NYSE:PFE – Free Report) – Equities research analysts at Leerink Partnrs boosted their FY2025 EPS estimates for shares of Pfizer in a research ...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 5 days agoPfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 3 days agoBoth stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more...
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Pfizer lifts profit forecast as CEO sees reason for optimism in 2024
Reuters via Yahoo Finance· 6 days ago(Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks· 6 days agoPfizer (PFE) beats first-quarter estimates for earnings and sales. It raises 2024 earnings guidance while retaining revenue expectations.
Albert Bourla
Time Magazine· 5 days agoWhen Albert Bourla became CEO of Pfizer in 2019, just before the pandemic, he wanted to make Pfizer’s medicines more affordable to more patients. “No...
Pfizer earnings beat by $0.29, revenue topped estimates By Investing.com
Investing.com· 6 days agoPfizer earnings beat by $0.29, revenue topped estimates
Earnings call: Pfizer raises 2024 EPS outlook despite revenue decline By Investing.com
Investing.com· 5 days agoPfizer Inc. (NYSE:PFE) reported its first-quarter financial results for 2024, indicating a solid...
Morgan Stanley Raises Pfizer (NYSE:PFE) Price Target to $29.00
ETF DAILY NEWS· 2 days agoPfizer (NYSE:PFE – Free Report) had its price target boosted by Morgan Stanley from $28.00 to $29.00 in a research report report published on Thursday, Benzinga reports. They ...